Toleris Biotherapeutics GmbH

Toleris Biotherapeutics GmbH is a biotechnology company based in Würzburg, Germany. The company specializes in the development of innovative biotherapeutic solutions aiming to advance the field of medicine through cutting-edge scientific research. As a leader in bio-pharmacological advancements, Toleris focuses on creating novel therapies for immune-mediated diseases by leveraging their robust understanding of biotherapy mechanics. Driven by a dedicated team of professionals, including CEO Prof. Dr. Jürgen Engel, CSO Dr. Valentin Bruttel, and Chief Scientific Advisor Prof. Dr. Jörg Wischhusen, the company is committed to pioneering biotherapeutics that strive to facilitate enhanced health outcomes for patients worldwide.